Non-Alcoholic Steatohepatitis (NASH) Market Size (USD 21.478 Billion by 2025) Set to Reach New Heights: Analysis of Trends and Growth Drivers

Non-alcoholic steatohepatitis (NASH), is a common liver disease, often called as silent liver disease. It is asymptomatic until its later stages, and thus many patients are unaware of their condition. NASH is projected to lead the cause of liver transplantation in the U.S. in the coming years. Some major factors such as higher prevalence of NASH, expected launch of pipeline drugs, and higher number of unmet needs drive the growth of this market. However, poor diagnosis of NASH due to the lack of ideal diagnostic technologies limit the growth of the NASH market.

Non-alcoholic steatohepatitis (NASH) market was valued at $1,179 million in 2017, and is expected to reach $21,478 million by 2025, growing at a CAGR of 58.4% from 2021 to 2025.

Some of the key players involved in the Market are:

Allergan Plc (Tobira Therapeutics Inc.), Genfit SA, Gemphire Therapeutics Inc., Intercept Pharmaceuticals, Inc., Gilead Sciences, Inc., Novartis International AG, Shire plc, Galmed Pharmaceuticals Ltd., Cadila Healthcare Ltd., Conatus Pharmaceuticals, Inc.

Download the Exclusive Sample Report @ https://www.alliedmarketresearch.com/request-sample/224

The Non-Alcoholic Steatohepatitis (NASH) market can be segmented based on several factors. Here are some common segmentation approaches used in the industry:

1. Disease Stage:
   • Pre-cirrhotic NASH: Refers to patients who have NASH but have not yet developed cirrhosis.
   • Cirrhotic NASH: Refers to patients with NASH who have developed liver cirrhosis.
2. Treatment Type:
   • Pharmacological Therapies: Includes medications specifically developed for NASH treatment, such as obeticholic acid (OCA), elafibranor, and selonsertib.
   • Lifestyle Modifications: Includes dietary changes, exercise, weight loss programs, and other non-pharmacological approaches.
3. Distribution Channel:
   • Hospital Pharmacies: Medications and treatments for NASH are prescribed and dispensed through hospital pharmacies.
   • Retail Pharmacies: Some NASH-related medications may be available through retail pharmacies for patients to purchase directly.
4. Geography:
   • Regional Markets: Different regions or countries may have varying prevalence rates of NASH, and the market dynamics can differ accordingly.
5. End-User:
   • Hospitals and Clinics: Medical facilities that provide diagnosis, treatment, and follow-up care for NASH patients.
   • Research Institutes: Institutions involved in NASH research, clinical trials, and development of new therapies.

Have Any Query? Ask Our Expert @: https://www.alliedmarketresearch.com/purchase-enquiry/224

𝐕𝐀𝐋𝐔𝐄 𝐏𝐑𝐎𝐏𝐎𝐒𝐈𝐓𝐈𝐎𝐍𝐒 𝐑𝐄𝐋𝐀𝐓𝐄𝐃 𝐓𝐎 𝐓𝐇𝐄 𝐑𝐄𝐏𝐎𝐑𝐓:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

Comprehensive quantitative and qualitative insights at segment and sub-segment level

Covid 19 impact trends and perspective

Granular insights at global/regional/country level

Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Blanket coverage on competitive landscape

Winning imperatives

Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com